Nashville-based Cumberland Pharmaceuticals Inc. recently announced second quarter results. In addition to year-to-date net revenues being up 25 percent from the prior year period, other highlights included continuation of a company-wide strategic review; expansion of sales team and national territories in support of key brands; finalization of the Vibativ agreements with Hikma Pharmaceuticals LLC for the Middle East, R. Pharma LLC for Russia and the CIS, and Dr. Reddy's Laboratories Ltd. for India; provision of additional data to the FDA in support of approval submission for a new line of methotrexate products designed for the treatment of patients with arthritis and psoriasis; and completed submission to the FDA in support of an update to the Caldolor approval that included new geriatric, shortened infusion, pediatric, and safety data.
Nashville-based Council Capital, a healthcare-focused private equity firm, recently announced it has sold its stake in Atlanta-based EspriGas to an entity affiliated with Kaltroco, a private investment company with operations in both the United States and Europe. EspriGas is a technology and data-driven medical and industrial gas company that utilizes a network business model to manage the gas supply chain. Since Council Capital's investment in 2013, EspriGas has more than doubled revenue and EBITDA and gained significant traction with customers in the healthcare vertical. Terms of the transaction were not disclosed.
LBMC has acquired Think Data Insights, a data analytics firm specializing in business intelligence for healthcare and several other industries.
A2H, Inc. has expanded to Middle Tennessee. Earlier this year, the Memphis-based collaborative planning and design firm merged with Brentwood-based M2 Design Services. The new A2H office, located in Franklin, is led by architect Rick McAllister, who previously founded M2 Design. A2H has deep experience in a number of industries, including healthcare.